Clinical Trial Simulations in Pediatric Patients Using Realistic Covariates: Application to Teduglutide, a Glucagon-Like Peptide-2 Analog in Neonates and Infants With Short-Bowel Syndrome

Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans

(2009) Brian J. Anderson et al.   Drug Metabolism and Pharmacokinetics

The In Silico Child: Using Simulation to Guide Pediatric Drug Development and Manage Pediatric Pharmacotherapy

(2009) Stephanie Läer et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Overview of Pediatric Short Bowel Syndrome

(2009) Debora Duro et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Teduglutide in intestinal adaptation and repair: light at the end of the tunnel

(2008) Houssam E Mardini et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Pharmacokinetics, Safety, and Tolerability of Teduglutide, a Glucagon-Like Peptide-2 (GLP-2) Analog, Following Multiple Ascending Subcutaneous Administrations in Healthy Subjects

(2008) Jean-Francois Marier et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Human renal function maturation: a quantitative description using weight and postmenstrual age

(2008) Malin M. Rhodin et al.   PEDIATRIC NEPHROLOGY